Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov-Dec;33(6S):S145-S146.
doi: 10.1097/DER.0000000000000875. Epub 2022 Jul 15.

Response Letter to the Editor: Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States

Raj Chovatiya, Wendy Smith Begolka, Isabelle J Thibau, Jonathan I Silverberg
Comment

Response Letter to the Editor: Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States

Raj Chovatiya et al. Dermatitis. 2022 Nov-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

R.C. has served as an advisory board member, consultant, and/or investigator for AbbVie, Arcutis, Arena, Dermavant Incyte, National Eczema Association, Pfizer, Regeneron, and Sanofi-Genzyme and speaker for AbbVie, Incyte, Regeneron, Sanofi-Genzyme, and UCB. J.I.S. reports personal fees from AbbVie, Anaptysbio, Asana, EliLilly, Galderma, GlaxoSmithKline, Kiniksa, Leo, Menlo, Pfizer, Realm, Regeneron­Sanofi, and Roivant and grants from GlaxoSmithKline, Regeneron­Sanofi, and Galderma. W.S.B. has served as an advisory board member and/or investigator for Incyte and Pfizer. I.J.T. has no funding or conflicts of interest to declare.

Comment on

References

    1. Smith Begolka W, Chovatiya R, Thibau IJ, Silverberg JI. Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States. Dermatitis. 2021. Oct 1;32(1S):S62–S70. doi: 10.1097/DER.0000000000000715. - DOI - PMC - PubMed
    1. Drucker AM, Cho E, Li WQ, Camargo CA Jr, Li T, Qureshi AA. Diagnosis validation and clinical characterization of atopic dermatitis in Nurses’ Health Study 2. J Eur Acad Dermatol Venereol. 2019. Mar;33(3):588–594. doi: 10.1111/jdv.15360. Epub 2019 Feb 18. - DOI - PMC - PubMed
    1. Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, White T, Kantor R, Hsu DY, Silverberg JI. Validation of patient-reported global severity of atopic dermatitis in adults. Allergy. 2018. Feb;73(2):451–458. doi: 10.1111/all.13309. Epub 2017 Oct 9. - DOI - PubMed
    1. Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults. Ann Allergy Asthma Immunol. 2018. Dec;121(6):729–734.e4. doi: 10.1016/j.anai.2018.07.040. Epub 2018 Aug 6. - DOI - PubMed
    1. Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, Brown M, Reaney M, Mahajan P, Guillemin I, Boguniewicz M, Pariser D. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol. 2019. Nov 6;19(1):15. doi: 10.1186/s12895-019-0095-3. - DOI - PMC - PubMed